KI
Kapitalo Investimentos Portfolio holdings
AUM
$459M
1-Year Return
18.25%
This Quarter Return
+4.96%
1 Year Return
+18.25%
3 Year Return
+64.59%
5 Year Return
+80.43%
10 Year Return
–
AUM
$303M
AUM Growth
+$173M
(+133%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
54.84%
Top 10 Holdings %
Top 10 Hldgs %
55.55%
Holding
522
New
340
Increased
51
Reduced
9
Closed
107
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
+$37.9M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$27M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$20.4M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$17.2M |
| 5 |
AJRD
Aerojet Rocketdyne Holdings, Inc.
AJRD
|
+$13.1M |
Top Sells
| 1 |
Amazon
AMZN
|
+$21.4M |
| 2 |
iShares MBS ETF
MBB
|
+$13.6M |
| 3 |
Sigma Lithium
SGML
|
+$13.5M |
| 4 |
AltShares Merger Arbitrage ETF
ARB
|
+$7.58M |
| 5 |
TransUnion
TRU
|
+$5.86M |
Sector Composition
| 1 | Healthcare | 12.14% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 8.86% |
| 4 | Financials | 5.96% |
| 5 | Utilities | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
East-West Bancorp
EWBC
$15.1B
| $133K | 0.04% |
+2,401
| New | +$133K |
|
252
US Bancorp
USB
$76.5B
| $132K | 0.04% |
+3,675
| New | +$132K |
|
253
Biogen
BIIB
$21.2B
| $132K | 0.04% |
475
+375
| +375% | +$104K |
|
254
Henry Schein
HSIC
$8.37B
| $132K | 0.04% |
+1,616
| New | +$132K |
|
255
AbCellera Biologics
ABCL
$1.34B
| $132K | 0.04% |
17,461
+5,561
| +47% | +$41.9K |
|
256
Quest Diagnostics
DGX
$20.5B
| $131K | 0.04% |
+929
| New | +$131K |
|
257
Exxon Mobil
XOM
$478B
| $131K | 0.04% |
1,192
+854
| +253% | +$93.7K |
|
258
Westlake Corp
WLK
$11.3B
| $131K | 0.04% |
+1,126
| New | +$131K |
|
259
Neonode
NEON
$72.3M
| $130K | 0.04% |
+17,121
| New | +$130K |
|
260
United Rentals
URI
$60.4B
| $130K | 0.04% |
+328
| New | +$130K |
|
261
Regions Financial
RF
$24.2B
| $129K | 0.04% |
+6,973
| New | +$129K |
|
262
Xenon Pharmaceuticals
XENE
$2.79B
| $129K | 0.04% |
+3,612
| New | +$129K |
|
|
HES
263
DELISTED
Hess
HES
| $129K | 0.04% |
976
+720
| +281% | +$95.3K |
|
264
Centene
CNC
$16.3B
| $128K | 0.04% |
+2,021
| New | +$128K |
|
265
Prothena Corp
PRTA
$442M
| $127K | 0.04% |
2,623
+1,323
| +102% | +$64.1K |
|
266
Cincinnati Financial
CINF
$24.5B
| $126K | 0.04% |
+1,126
| New | +$126K |
|
267
Core Laboratories
CLB
$581M
| $126K | 0.04% |
5,695
+2,495
| +78% | +$55K |
|
268
Incyte
INCY
$16.2B
| $125K | 0.04% |
+1,730
| New | +$125K |
|
269
ADT
ADT
$7.24B
| $125K | 0.04% |
+17,285
| New | +$125K |
|
270
VF Corp
VFC
$5.8B
| $125K | 0.04% |
+5,451
| New | +$125K |
|
271
ATI
ATI
$10.5B
| $125K | 0.04% |
+3,158
| New | +$125K |
|
272
United Therapeutics
UTHR
$18.3B
| $124K | 0.04% |
+554
| New | +$124K |
|
273
Xylem
XYL
$34.5B
| $123K | 0.04% |
+1,179
| New | +$123K |
|
274
Las Vegas Sands
LVS
$36.7B
| $122K | 0.04% |
+2,116
| New | +$122K |
|
275
Charles River Laboratories
CRL
$7.52B
| $121K | 0.04% |
+600
| New | +$121K |
|